Phase II trial of talactoferrin alfa in combination with paclitaxel and carboplatin as first-line therapy in patients with non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 26 May 2011
At a glance
- Drugs Carboplatin; Paclitaxel; Talactoferrin alfa
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 26 May 2011 Results published in the Journal of Thoracic Oncology, according to an Agennix media release.
- 05 Nov 2010 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History